Buscar
Procept Biorobotics Corp
PRCTAñadir a la lista de seguimiento
26.430USD
+0.730+2.84%
Cierre 05/14, 16:00（ET）Cotizaciones retrasadas 15 min
1.50BCap. mercado
PérdidaP/E TTM
Más Datos de Procept Biorobotics Corp Compañía
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Información de Procept Biorobotics Corp
Símbolo de cotizaciónPRCT
Nombre de la empresaProcept Biorobotics Corp
Fecha de salida a bolsaSep 15, 2021
Director ejecutivoWood (Larry L)
Número de empleados756
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 15
Dirección150 Baytech Drive
CiudadSAN JOSE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal95134
Teléfono16502329832
Sitio Webhttps://www.procept-biorobotics.com/
Símbolo de cotizaciónPRCT
Fecha de salida a bolsaSep 15, 2021
Director ejecutivoWood (Larry L)
Ejecutivos de Procept Biorobotics Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
861.62K
-0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
132.71K
-1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.68K
-38.27%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
12.85K
-11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
786.00
-395.67%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
861.62K
-0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
132.71K
-1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.68K
-38.27%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
12.85K
-11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Hand pieces and other consumables
181.45M
58.90%
System sales and rentals
106.13M
34.45%
Service
20.48M
6.65%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
270.38M
87.77%
Outside United States
37.68M
12.23%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Hand pieces and other consumables
181.45M
58.90%
System sales and rentals
106.13M
34.45%
Service
20.48M
6.65%
Estadísticas de accionistas
Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
8.10%
BlackRock Institutional Trust Company, N.A.
6.66%
AllianceBernstein L.P.
5.95%
T. Rowe Price Investment Management, Inc.
5.75%
Vanguard Portfolio Management, LLC
4.25%
Otro
69.29%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
8.10%
BlackRock Institutional Trust Company, N.A.
6.66%
AllianceBernstein L.P.
5.95%
T. Rowe Price Investment Management, Inc.
5.75%
Vanguard Portfolio Management, LLC
4.25%
Otro
69.29%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
62.23%
Investment Advisor/Hedge Fund
27.95%
Hedge Fund
8.01%
Research Firm
3.63%
Individual Investor
3.13%
Pension Fund
1.16%
Bank and Trust
1.00%
Venture Capital
0.84%
Sovereign Wealth Fund
0.15%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
597
65.01M
114.22%
-1.01M
2025Q4
573
59.92M
107.23%
-2.03M
2025Q3
536
55.75M
99.78%
-1.67M
2025Q2
535
55.45M
100.20%
-990.27K
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
4.61M
8.18%
-3.28M
-41.57%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.79M
6.72%
+62.83K
+1.69%
Dec 31, 2025
AllianceBernstein L.P.
3.39M
6%
-34.36K
-1.00%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
3.27M
5.8%
+1.22M
+59.38%
Dec 31, 2025
Chicago Capital, LLC
1.19M
2.11%
-377.85K
-24.08%
Dec 31, 2025
BNP Paribas Asset Management USA, Inc.
1.85M
3.28%
+757.43K
+69.38%
Dec 31, 2025
Mackenzie Financial Corporation
1.57M
2.79%
+118.97K
+8.18%
Dec 31, 2025
State Street Investment Management (US)
1.49M
2.64%
+164.36K
+12.41%
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Global X HealthTech ETF
1.64%
State Street SPDR S&P Health Care Equipment ETF
1.62%
ALPS Disruptive Technologies ETF
0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.7%
Global X Robotics & Artificial Intelligence ETF
0.7%
Main Thematic Innovation ETF
0.46%
Harbor Health Care ETF
0.35%
Langar Global HealthTech ETF
0.32%
iShares U.S. Medical Devices ETF
0.22%
Nuveen ESG Small-Cap ETF
0.17%
Ver más
Global X HealthTech ETF
Proporción1.64%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.62%
ALPS Disruptive Technologies ETF
Proporción0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.7%
Global X Robotics & Artificial Intelligence ETF
Proporción0.7%
Main Thematic Innovation ETF
Proporción0.46%
Harbor Health Care ETF
Proporción0.35%
Langar Global HealthTech ETF
Proporción0.32%
iShares U.S. Medical Devices ETF
Proporción0.22%
Nuveen ESG Small-Cap ETF
Proporción0.17%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
